GMTX
Gemini Therapeutics Inc
Price:  
1.35 
USD
Volume:  
63,882.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GMTX Intrinsic Value

-100.00 %
Upside

What is the intrinsic value of GMTX?

As of 2025-07-04, the Intrinsic Value of Gemini Therapeutics Inc (GMTX) is - USD. This GMTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.35 USD, the upside of Gemini Therapeutics Inc is -100.00%.

Is GMTX undervalued or overvalued?

Based on its market price of 1.35 USD and our intrinsic valuation, Gemini Therapeutics Inc (GMTX) is overvalued by 100.00%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

1.35 USD
Stock Price
- USD
Intrinsic Value
Intrinsic Value Details

GMTX Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value - - - - -100.00%
P/E (14.22) - (20.23) (14.54) -1176.7%
DDM - Stable (10.24) - (29.89) (20.06) -1586.2%
DDM - Multi (6.66) - (15.26) (9.29) -788.3%

GMTX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 58.49
Beta 1.10
Outstanding shares (mil) 43.33
Enterprise Value (mil) -319.11
Market risk premium 5.00%
Cost of Equity 9.32%
Cost of Debt 5.00%
WACC 6.50%